China receives approval for selling a rare disease medicine
On Sunday, March 28th, government officials of China announced that the world’s only medicine treating Spinal Muscular Atrophy (SMA) will now be available in the Chinese markets. In the United States and European Union, the drug is registered under the name Spinraza. As per reports, Spinraza is available in nearly 40 countries and regions. According to…